I wouldn't read too much into the price movements. This stock has a backlog of LT holders who would have had an investment horizon of a few years, unfortunately not everything has gone to plan in the past and people are using the jumps to reduce holdings. These positive announcements are good to flush out the old and encourage new holders (who hopefully understand how biotec companies develop), as stable register is always a good thing.
What's needed for a real price rise is a consistent pipeline of FDA approved products + manufacturing capacity + solid funding facilities + consistent volume + Management with a strategic direction. These significant announcements, when they do come, will be the catalyst for realising the true value of this company, as PXS already possesses more than a few of the key ingredients IMO.
PXS Price at posting:
9.1¢ Sentiment: Hold Disclosure: Held
